Profile
Full Name
Aligos Therapeutics, Inc.Ticker Symbol
ALGSExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 16, 2020Indexes
Not includedWebsite
http://www.aligos.comEmployees
70Key Details
Price
$4.45(-5.72%)
Market cap
$27.21M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$3.94M(-74.60% YoY)
Annual EPS
-$20.94(+38.77% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Aligos Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 31, 25 HC Wainwright & Co.
BuyMar 11, 25 HC Wainwright & Co.
BuyNov 7, 24 HC Wainwright & Co.
BuyOct 23, 24 HC Wainwright & Co.
BuySep 20, 24 HC Wainwright & Co.
BuyAug 19, 24 HC Wainwright & Co.
BuyJan 17, 23 Piper Sandler
OverweightJan 6, 23 Piper Sandler
OverweightJan 6, 23 Jefferies
BuyNov 3, 22 SVB Leerink
Market PerformInstitutional Ownership
- What is the ticker symbol for Aligos Therapeutics?
- Does Aligos Therapeutics pay dividends?
- What sector is Aligos Therapeutics in?
- What industry is Aligos Therapeutics in?
- What country is Aligos Therapeutics based in?
- When did Aligos Therapeutics go public?
- Is Aligos Therapeutics in the S&P 500?
- Is Aligos Therapeutics in the NASDAQ 100?
- Is Aligos Therapeutics in the Dow Jones?
- When was Aligos Therapeutics's last earnings report?
- When does Aligos Therapeutics report earnings?
- Should I buy Aligos Therapeutics stock now?
What is the ticker symbol for Aligos Therapeutics?
The ticker symbol for Aligos Therapeutics is NASDAQ:ALGS
Does Aligos Therapeutics pay dividends?
No, Aligos Therapeutics does not pay dividends
What sector is Aligos Therapeutics in?
Aligos Therapeutics is in the Healthcare sector
What industry is Aligos Therapeutics in?
Aligos Therapeutics is in the Biotechnology industry
What country is Aligos Therapeutics based in?
Aligos Therapeutics is headquartered in United States
When did Aligos Therapeutics go public?
Aligos Therapeutics's initial public offering (IPO) was on October 16, 2020
Is Aligos Therapeutics in the S&P 500?
No, Aligos Therapeutics is not included in the S&P 500 index
Is Aligos Therapeutics in the NASDAQ 100?
No, Aligos Therapeutics is not included in the NASDAQ 100 index
Is Aligos Therapeutics in the Dow Jones?
No, Aligos Therapeutics is not included in the Dow Jones index
When was Aligos Therapeutics's last earnings report?
Aligos Therapeutics's most recent earnings report was on Mar 10, 2025
When does Aligos Therapeutics report earnings?
The next expected earnings date for Aligos Therapeutics is May 7, 2025
Should I buy Aligos Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions